The Impact of Systemic Light Chain Amyloidosis on Eyes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Impact of Systemic Light Chain Amyloidosis on Eyes — Stella

Recruiting

Back to Systemic Light Chain Amyloidosis trials

Trial locations(1 site)

China

Zhongshan Opthalmic Center, Guangzhou, Guangdong

Key details

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Enrollment target

~130 participants

Started

September 2024

Primary completion

August 2026

Age range

18 Years – 80 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov